All reports
Pharmaceutical
Oncology, Cell & Gene Therapy
CRISPR and Gene Editing: Clinical Pipeline
Code: NSC/PHRM/0007Published May 04, 2026
About this report
Casgevy (Vertex/CRISPR Tx), Editas, Beam, Verve: sickle cell disease, cardiovascular, ophthalmology.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.